Atrium Therapeutics, Inc. (RNA)
Atrium Therapeutics Market Cap : 210.40M for June 4, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Tenax Therapeutics, Inc. | 269.22M |
| Exicure, Inc. | 18.87M |
| Century Therapeutics, Inc. | 396.23M |
| Absci Corp. | 1.140B |
| Celularity, Inc. | 28.69M |
Market Cap Related Metrics
| PS Ratio | 8.405 |
| Price to Book Value | 0.8987 |
| Price | 12.30 |
| Earnings Yield | -30.76% |